Legal & Courts  September 9, 2022

Statera Biopharma faces involuntary bankruptcy petition

FORT COLLINS — Statera Biopharma Inc. (Nasdaq: STAB) was served last month with a petition from its creditors to involuntarily force the company into Chapter 11 bankruptcy, according to documents filed with U.S. Bankruptcy Court in Denver.

In the petition, creditors are seeking to recover about $7.73 million in total.

The creditors in the initial petition are Noreen Griffin, Stephen Wilson and Peter Aronstam, who are claiming a total of $2.09 million in unpaid wages and severance.

The petition was followed by several additional joinders by other creditors, including:

  • More former employees seeking about $2.5 million in unpaid wages…

Related Posts

Sign up for BizWest Daily Alerts